C15.9 ICD-10-CM Code: Malignant neoplasm of esophagus, unspecified
C15.9 maps to CMS-HCC V28 20. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of digestive organs (C15-C26)
C15.9
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceMalignant neoplasm of esophagus, unspecified
Cancer of the esophagus where the specific section or location is not documented or specified.

Buddy Insight
Unspecified esophageal cancer represents a documentation gap where the specific anatomical segment is unknown, yet the diagnosis still carries significant risk adjustment weight.
CMS-HCC V28
MappedHCC 20
Code-level coefficient reference
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 009
Code-level coefficient reference
ESRD/PACE
MappedHCC 9
Code-level coefficient reference
RXHCC
N/A—
Not mapped
Code Book Path
Inclusion Terms
OfficialNo inclusion terms are included in this display for C15.9. Check the code and parent instructions in the Code Book.
Excludes 2
Official- gastrointestinal stromal tumors (C49.A-)Inherited from C15-C26
Related Codes
Includes
OfficialNo Includes notes are included in this display for C15.9. Check the code and parent instructions in the Code Book.
Excludes 1
Official- Kaposi's sarcoma of gastrointestinal sites (C46.4)Inherited from C15-C26
Code First
OfficialNo Code First sequencing instructions are included in this display for C15.9. Check the code and parent instructions in the Code Book.
Use Additional
Official- code to identify:Inherited from C15
- alcohol abuse and dependence (F10.-)Inherited from C15
Code Also
OfficialNo Code Also instructions are included in this display for C15.9. Check the code and parent instructions in the Code Book.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is C15.9 an HCC code?
Yes. C15.9 (Malignant neoplasm of esophagus, unspecified) maps to HCC 20, Lung and Other Severe Cancers under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 1.136. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.
Coder answer: C15.9 is billable and maps to V28 HCC 20, Lung and Other Severe Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- C15.9
- Description
- Malignant neoplasm of esophagus, unspecified
- HCC (V28)
- HCC 20 — Lung and Other Severe Cancers
- RAF reference coefficient
- 1.136
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work C15.9 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for C15.9
For C15.9, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
C15.9 is the ICD-10-CM diagnosis code for malignant neoplasm of esophagus, unspecified. Cancer of the esophagus where the specific section or location is not documented or specified. C15.9 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of digestive organs (c15-c26).
Under the CMS-HCC V28 risk adjustment model, C15.9 maps to Lung and Other Severe Cancers (HCC 20) with a source-labeled community, non-dual, aged reference coefficient of 1.136. No V24 mapping is shown for C15.9; use the applicable model and payment year when reviewing the V28 mapping. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.
This is a default code used when documentation does not specify which part of the esophagus is affected. For C15.9, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C15.9 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This is a default code used when documentation does not specify which part of the esophagus is affected
- •Query the provider if possible to obtain more specific anatomical location for better coding accuracy
Clinical Significance
Unspecified esophageal cancer represents a documentation gap where the specific anatomical segment is unknown, yet the diagnosis still carries significant risk adjustment weight. While clinically this code captures the same disease burden as specified esophageal cancer codes, it signals an opportunity to improve documentation specificity. Esophageal cancer has a five-year survival rate under 20%, reflecting the high resource needs captured by this HCC.
Documentation Requirements
- ✓Confirmed malignancy of the esophagus (pathology or clinical diagnosis)
- ✓Attempt to identify specific segment from endoscopy, imaging, or surgical reports
- ✓Histological type if available
- ✓Current treatment status (active, surveillance, remission)
- ✓Stage of disease if documented
Commonly Confused Codes
- •C15.3, C15.4, C15.5: Specific esophageal segments: always use the more specific code when documentation supports it
- •C15.8: Overlapping sites: use when tumor is known to span multiple segments, not when segment is unknown
- •D00.1: Carcinoma in situ of esophagus: completely different behavior classification; in situ is pre-invasive and does not map to an HCC
- •Z85.01: Personal history of malignant neoplasm of esophagus: use when cancer is completely excised and no longer under treatment

